Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Raffaella Barbaro

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Opinion in Pharmacology|September 17, 2018
Pre- and probiotic overviewCesare Cremon, Maria Raffaella Barbaro, Marco Ventura, et al.
F1000Research|October 27, 2018
Recent advances in understanding non-celiac gluten sensitivityMaria Raffaella Barbaro, Cesare Cremon, Vincenzo Stanghellini, et al.
Microbiome Research Reports|December 4, 2023
Gut microbiota signatures and modulation in irritable bowel syndromeGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Journal of Clinical Gastroenterology|January 16, 2024
Journal of Clinical Gastroenterology Lectureship Dubai 2022 : Management of Irritable Bowel Syndrome With DiarrheaGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Expert Opinion on Investigational Drugs|February 17, 2018
Advancements in drug development for diarrhea-predominant irritable bowel syndromeGiovanni Dothel, Maria Raffaella Barbaro, Emanuel Raschi, et al.
International Journal of Molecular Sciences|March 27, 2025
A Probiotic Mixture of <i>Lactobacillus rhamnosus</i> LR 32, <i>Bifidobacterium lactis</i> BL 04, and <i>Bifidobacterium longum</i> BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1Maria Raffaella Barbaro, Francesca Bianco, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2023
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome-Authors' replyGiovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2023
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndromeGiovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2024
Microbiota modulation in disorders of gut-brain interactionGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Neurogastroenterology and Motility|May 27, 2023
The role of microbiota and its modulation in colonic diverticular diseaseGiovanni Marasco, Francesco Buttitta, Cesare Cremon, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Opinion in Pharmacology|September 17, 2018
Pre- and probiotic overviewCesare Cremon, Maria Raffaella Barbaro, Marco Ventura, et al.
F1000Research|October 27, 2018
Recent advances in understanding non-celiac gluten sensitivityMaria Raffaella Barbaro, Cesare Cremon, Vincenzo Stanghellini, et al.
Microbiome Research Reports|December 4, 2023
Gut microbiota signatures and modulation in irritable bowel syndromeGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Journal of Clinical Gastroenterology|January 16, 2024
Journal of Clinical Gastroenterology Lectureship Dubai 2022 : Management of Irritable Bowel Syndrome With DiarrheaGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Expert Opinion on Investigational Drugs|February 17, 2018
Advancements in drug development for diarrhea-predominant irritable bowel syndromeGiovanni Dothel, Maria Raffaella Barbaro, Emanuel Raschi, et al.
International Journal of Molecular Sciences|March 27, 2025
A Probiotic Mixture of <i>Lactobacillus rhamnosus</i> LR 32, <i>Bifidobacterium lactis</i> BL 04, and <i>Bifidobacterium longum</i> BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1Maria Raffaella Barbaro, Francesca Bianco, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2023
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome-Authors' replyGiovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Alimentary Pharmacology & Therapeutics|April 11, 2023
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndromeGiovanni Marasco, Marcello Maida, Cesare Cremon, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2024
Microbiota modulation in disorders of gut-brain interactionGiovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Neurogastroenterology and Motility|May 27, 2023
The role of microbiota and its modulation in colonic diverticular diseaseGiovanni Marasco, Francesco Buttitta, Cesare Cremon, et al.
Pageof 5